{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:45:54Z","timestamp":1760546754988},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1006\/gyno.2002.6584","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T18:32:46Z","timestamp":1033929166000},"page":"136-139","source":"Crossref","is-referenced-by-count":7,"title":["A Phase I Trial of Prolonged Oral Etoposide and Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study"],"prefix":"10.1006","volume":"85","author":[{"given":"Peter G.","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Greer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2002.6584_RF1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1200\/JCO.1994.12.1.60","article-title":"Oral etoposide is active against platinum-resistant epithelial ovarian cancer","volume":"12","author":"Hoskins","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.1998.16.2.405","article-title":"Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study","volume":"16","author":"Rose","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF4","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1200\/JCO.2000.18.17.3093","article-title":"Phase II study of Stealth\u00ae liposomal doxorubicin (Doxil\u00ae) in platinum and paclitaxel refractory epithelial ovarian cancer","volume":"18","author":"Gordon","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF5","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.1998.16.10.3345","article-title":"Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after chemotherapy that contained cisplatin or carboplatin and paclitaxel","volume":"16","author":"Bookman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1006\/gyno.1997.4787","article-title":"Topotecan in platinum- and paclitaxel-resistant ovarian cancer","volume":"66","author":"Swisher","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6584_RF7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/gyno.1996.0284","article-title":"Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel","volume":"63","author":"Shapiro","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2002.6584_RF8","unstructured":"Chen, M, D. A phase I study of gemcitabine\/topotecan in combination in recurrent or persistent ovarian or peritoneal cancer or cancer of the fallopian tube. Personal communication."},{"key":"10.1006\/gyno.2002.6584_RF9","first-page":"405a","article-title":"Phase I trial of gemcitabine and protracted oral etoposide in recurrent gynecologic tumors: a Gynecologic Oncology Group study","volume":"19","author":"Lentz","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF10","unstructured":"Rose, P, G. A phase I study of sequential prolonged oral topotecan and prolonged oral etoposide as second line therapy in ovarian, peritoneal or tubal carcinoma. Personal communication."},{"key":"10.1006\/gyno.2002.6584_RF11","first-page":"891","article-title":"Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes","volume":"52","author":"Gabizon","year":"1992","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2002.6584_RF12","first-page":"359a","article-title":"Lack of improvement in survival in patients with relapsed or refractory epithelial ovarian cancer, 1980\u20131997","volume":"17","author":"Knopf","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF13","first-page":"236","article-title":"Prolonged administration of oral etoposide in previously-treated epithelial ovarian cancer: a phase II trial","volume":"11","author":"Garrow","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/bjc.1994.33","article-title":"Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease","volume":"69","author":"Seymour","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.2002.6584_RF15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/oxfordjournals.annonc.a058942","article-title":"Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy","volume":"5","author":"DeWit","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1006\/gyno.2002.6584_RF16","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial","volume":"16","author":"Northfelt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2002.6584_RF17","first-page":"36","article-title":"The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer","volume":"19","author":"Clark","year":"1992","journal-title":"Semin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825802965844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825802965844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T05:59:17Z","timestamp":1557295157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825802965844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0090825802965844"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2002.6584","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}